InvestorsHub Logo
Followers 21
Posts 3247
Boards Moderated 0
Alias Born 03/10/2017

Re: BIOChecker4 post# 229253

Wednesday, 01/08/2020 1:43:50 PM

Wednesday, January 08, 2020 1:43:50 PM

Post# of 462553
CTAD 2019 ANAVEX P2a AD presentation has proven that A2-73 is efficacious with p < 0.01! You are wrong.

A2-73 has proven efficacious as a therapy modifying Alzheimer’s.

This therapy will be worth “$13B to $67B in revenue per month.”

So the stock price will be between $2600 and $13400!

To cover the 6.5M short interest at the least sp estimate will require $169B!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News